MANGALAMNSEMangalam Drugs And Organics Limited· PharmaceuticalsMediumNeutral
Announced Thu, 26 Mar · 13:02 IST

Mangalam Drugs And Organics Limited has informed the Exchange about Change in Company Secretary/Compliance Officer

Kmp ResignedManagement Changes View source PDF

MANGALAM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-9.2%1-day move
₹29.80
prior close
₹29.80
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.3+1.3-3.5-1.2-9.2-4.4-2.7+2.3+0.4+9.0-5.4-6.7-3.7-4.9
Up moveDown movePending
AI summary

Mangalam Drugs and Organics has accepted the resignation of Ms. Anuradha Pandey from the post of Company Secretary & Compliance Officer, with her last working day set for March 29, 2026. She is stepping down to pursue opportunities outside the company. To fill the role, the board has approved the appointment of Ms. Shweta Patel as the new Company Secretary and Compliance Officer, effective April 1, 2026. Shweta Patel is a B.Com graduate and an Associate Member of the Institute of Company Secretaries of India with about 3 years of experience in corporate compliance for listed companies. The board approved these changes at its meeting on March 26, 2026, which ran from 12:00 PM to 12:40 PM.

Likely market impact

This is a routine KMP-level change with no negative governance red flags — the outgoing Company Secretary left voluntarily for external opportunities, and a qualified replacement is already lined up with no gap in compliance responsibilities. Shareholders are unlikely to see any material impact on the stock or operations.